Literature DB >> 11531607

Alzheimer's disease and estrogen replacement therapy--where are we now?

P Polo-Kantola1, R Erkkola.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11531607     DOI： 10.1034/j.1600-0412.2001.080008679.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN： 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  2 in total

1.  Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons.

Authors:  S-Y Park; C Tournell; R C Sinjoanu; A Ferreira
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

2.  Estrogen Protects Optic Nerve Head Astrocytes Against Oxidative Stress by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser422 and the Formation of Tau Protein Aggregates.

Authors:  John C Means; Adam A Lopez; Peter Koulen
Journal:  Cell Mol Neurobiol       Date:  2020-05-08       Impact factor: 5.046
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.